医学
流行病学
肺癌
多中心研究
人口
内科学
入射(几何)
前瞻性队列研究
癌症
肿瘤科
呼吸道疾病
风险因素
肺病
肺
基于人群的研究
风险评估
梅德林
儿科
癌症流行病学
队列研究
作者
Wenhua Liang,Yongzhao Zhou,Chengping Hu,Wei Xiao,Jian Zhang,Min Li,Wei Wang,Xianwei Ye,Xiangyan Zhang,Ning Chang,Chunmei Yun,Dejun Sun,Yunhui Zhang,Zheng Qin,Wei Wang,Yong Zhang,Xin Yu ZHANG,Yi Xiang,瞿介明,Wei Zhang
标识
DOI:10.1016/j.jncc.2026.03.003
摘要
Background: Lung cancer incidence and mortality continue to rise in China, highlighting the need for a deeper understanding of its epidemiology and optimal screening targets. Methods: A total of 10,560 participants with 5-30 mm pulmonary nodules incidentally detected via low-dose computed tomography (LDCT)/CT were enrolled from 23 hospitals (October 2018-May 2021) and followed for 2-3 years for evaluation of circulating tumor DNA (ctDNA) biomarkers to distinguish malignant and benign nodules. Demographic, clinical, and imaging data were collected and analyzed. Lung cancer risk factors were assessed using stepwise single and multiple-factor binary logistic regression. This study reports only the baseline epidemiological characteristics of the population and the associated risk factors of lung cancer. Results: < 0.001). While 97.1% of females and 37.8% of males were non-smokers, and 68.65% of participants had no occupational exposure, 71.10% had a history of second-hand smoke exposure. Most nodules were solitary (81.24%), sub-centimeter (78.22%), and non-solid (62.49%). Malignancy was identified in 17.33% of nodules, with 97.32% classified as early-stage lung adenocarcinoma (AJCC stage 0-I: 90.35%). The malignant rate increased with age and nodule size and was also associated with multiple nodules, ground-glass nodules (GGNs), upper lobe location, and female sex. Proportion of patients with malignant nodules was similar between non-high-risk (21.04%) and high-risk (17.92%) groups based on current Chinese screening guidelines, while proportions of benign nodules were notably high for solid nodules (37.21%) and small nodules (20.15%). Conclusion: Our large-scale investigation provides updated data to guide future precise clinical management of pulmonary nodules, with a particular focus on younger females and reducing overtreatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI